AI-Driven Virtual Screening of Naturalcompounds Against SARS-CoV-2 Using Embedding-Based Drug-Protein Interaction Prediction
The imperative necessity for rapid discovery of antiviral agents against emerging viral diseases, such as COVID-19 caused by SARS-CoV-2, has emphasised the limitations of conventional drug discovery, with its deliberate pace, high costs, and high failure rate. In this study, we present a high-throughput “AI-driven virt...